New: Nuclera Expands eProtein Discovery™ with New Membrane Protein Workflow - Read Now

Nuclera News

Read our latest press releases and news developments

Filter by

News Type

Company Announcements
General News
Investor News

Year

2021
2022
2023
2024
2025

General News

Nuclera Announces Professor Michael Jewett as new member of the Scientific Advisory Board

October 24, 2022

General News

Announcing our new headquarters in Cambridge, UK

August 1, 2022

Investor News

Nuclera raises additional capital for eProtein™ desktop bioprinter to close Series B funding at $58M.

July 6, 2022

Company Announcements

Nuclera Announces Appointment of Colin Barnes and Kristine Friscino to its Executive Leadership Team

June 3, 2022

Company Announcements

Nuclera Announces Appointment of Two New VPs, Charu Maini and Eugene Bragin

May 5, 2022

Investor News

Nuclera raises $42.5M in first close of Series B for desktop protein printer

February 2, 2022

General News

Nuclera presents at Edison Open House: Global Healthcare 2021

January 26, 2022

Company Announcements

Nuclera announces expansion with new US subsidiary

January 18, 2022

General News

Dr Joe Keegan joins Nuclera’s board as non-executive director

July 21, 2021

General News

Nuclera Acquires E Ink Digital Microfluidics Unit

May 12, 2021

Pages: 1234

eProtein Discovery System

The only end-to-end protein prototyping solution

menu-main-menu-img

Instrument-menu

Instrument

Cartridge

Reagents

Software